HOME > 教室について > 業績リスト > 【発表論文】英文 > 1996年

1996年

  1. Sasayama S, Matsumori A: Role of cytokines in the syndrome of heart failure. Internal Medicine 35: 60-63.
  2. Sasayama S: Pharmacology of vesnarinone: research findings on a potential cytokine inhibitor. In Therapies for Heart Failure: A Grimpse into the Future, ed by R. Roberts, Discovery International, Deerfield, Illinois, pp. 19-26.
  3. Sasayama S, Matsumori A, Matsui S, Shioi T, Yamada T: Immunomodulating effects as new aspects of a positive inotropic agent. In Molecular and Cellular Mechanisms of Cardiovascular Regulation, ed. by Endoh M, Morad M, Scholz H, Iijima T, Springer-Verlag, Tokyo, pp. 433-443.
  4. Sasayama S, Matsumori A, Matsui S, Hirozane T, Yamada T, Kishimoto C: Immunomodulatory therapy and survival with cardiac disease. Heart Failure Reviews 1: 221-227.
  5. Sasayama S, Matsumori A: Vesnarinone: a potential cytokine inhibitor. J Cardiac Fail 2: 251-258.
  6. Sasayama S, Matsumori A, Matoba Y, Matsui S, Yamada T, Shioi T, Sato Y, Doyama K, Kishimoto C: Immunomodulation: a new horizon for medical treatment of heart failure. J Cardiac Fail 2: S287-S294.
  7. Sasayama S: Inotropic agents in the treatment of heart failure: despair or hope? Cardiovasc Drugs Ther 10: 703-709.
  8. Asanoi H, Ishizaka S, Kameyama T, Sasayama S: Positive inotropic therapy for chronic heart failure: new perspective on therapeutic strategies. In New Horizons for Failing Heart Syndrome, ed. by Sasayama S, Springer, Tokyo, pp. 209-218.
  9. Asanoi H, Ishizaka S, Joho S, Kameyama T, Inoue H, Sasayama S: Altered inotropic and lusitropic responses to heart rate in conscious dogs with tachycardia-induced heart failure. J Am Coll Cardiol 27:728-735.
  10. Kohno F, Kumada TT, Kambayashi M, Hayashida W, Ishikawa N, Sasayama S: Change in aorticend-systolic pressure by alterations in loading sequence and its relationto left ventricular isovollumic relaxation. Circulation 93: 2080-2087.
  11. Hayashida W, Kumada T, Kambayashi M, Ishikawa N, Sasayama S: Early diastolic regional function of the hypertrophied left ventricle. Int J Cardiol 53: 153-162.
  12. Furukawa Y, Matsumori A, Hirozane T, Sasayama S: Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. Circulation 93: 333-339.
  13. Matsumori A, Yamada T, Matsui S, Shioi T, Sasayama S: Cytokines and heartfailure: Immunomodulating agents for the management of heart failure. In New Horizons for Failing Heart Syndrome, Edited by Sasayama S, Springer-Verlag, Tokyo, pp. 219-232.
  14. Matsumori A, Furukawa Y, Hashimoto T, Ono K, Shioi T, Okada M, Iwasaki A, Nishio R, Sasayama S: Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction. Biochem Biophys Res Commun 221: 391-395.
  15. Furukawa Y, Matsumori A, Hirozane T, Matsui S, Sato Y, Ono K, Sasayama S: Immunomodulation by an adenylate cyclase activator, NKH477, in vivo and in vitro. Clin Immunol Immunopathol 79: 25-35.
  16. Matsumori A, Matoba Y, Nishio R, Shioi T, Ono K, Sasayama S: Detection of hepatitis C virus RNA from the heart of patients with hypertrophic cardiomyopathy. Biochem Biophys Res Commun 222: 678-682.
  17. Matsumori A: Cytokines in myocarditis and cardiomyopathies. Curr Opin Cardiol 11: 302-309.
  18. Matsumori A, Yamada T, Sasayama S: Antimyosin antibody imaging in clinical myocarditis and cardiomyopathy: principle and application. Int J Cardiol 54: 183-190.
  19. Matsumori A, Okada I, Shioi T, Furukawa Y, Nakamura T, Ono K, Iwasaki A, Sasayama S: Inotropic agents differentially inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages. Life Sci 59: PL121-PL125.
  20. Nakamura H, Yamamura T, Fukuta S, Matsumori A, Matsuzaki M: A pathogenic mechanisms of chronic ongoing myocarditis. Jpn Circ J 60: 609-617.
  21. Matsumori A, Ono K, Sato Y, Shioi T, Nose Y, Sasayama S: Differential modulation of cytokine production by drugs: Implication for therapy in heart failure. J Mol Cell Cardiol 28: 2491-2499.
  22. Shioi T, Matsumori A, Sasayama S: Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. Circulation 94: 2930-2937.
  23. Matsumori A, Sasayama S: Newer aspects of pathogenesis of heart failure: Hepatitis C virus infection in myocarditis and cardiomyopathy. J Cardiac Failure 2(Suppl.): S187-S194.
  24. Tadamura E, Tamaki N, Matsumori A, Magata Y, Yonekura Y, Nohara R, Sasayama S, Yoshibayashi M, Kamiya T, Konishi J: Myocardial metabolic changes in hypertrophic cardiomyopathy. J Nucl Med 37: 572-577.
  25. Nakamura H, Yamamura T, Umemoto S, Fukuta S, Matsumori A, Matsuzaki M: Autoimmune response in chronic ongoing myocarditis demonstrated by heterotopic cardiac transplantation in mice. Circulation 94: 3348-3354.
  26. Sato Y, Takatsu Y, Ito H, Kataoka K, Takeuchi Y, Matsumori A: Elevated circulating levels of tumor necrosis factor in patients with mitral valve disease and ventricular septum defect. Heart Vessels 11: 218-220.
  27. Nagai K, Murakami T, Iwase T, Tomita T, Sasayama S: Digoxin reduces ｧ-adrenergic contractile response in rabbit hearts. Ca2+-dependent inhibition of adenylyl cyclase activity via Na+/Ca2+ exchange. J Clin Invest 97: 6-13.
  28. Muso E, Yoshida H, Takeuchi E, Yashiro M, Matsushima H, Oyama A, Suyama K, Kawamura T, Kamata T, Miyawaki S, Izui S, Sasayama S: Enhanced production of glomerular extracellular matrix in a new mouse strain established by selective mating of high serum IgA ddY (HIGA) mice. Kidney Int 50: 1946-1957.
  29. Koide M, Furukawa F, Wakita H, Tokura Y, Muso E, Takigawa M: Soluble form of vascular cell adhesion molecule-1 in systemic lupus erythematosus and discoid lupus erythematosus. J Dematol Sci 12: 73-75.
  30. Hata T, Nohara R, Fujita M, Hosokawa R, Li L, Kudoh T, Tadamura E, Tamaki N, Konishi J, Sasayama S: Noninvasive assessment of myocardial viability by positron emission tomography with 11C acetate in patients with old myocardial infarction: Usefulness of low-dose dobutamine infusion. Circulation 94: 1834-1841.
  31. Fujibayashi Y, Nohara R, Hosokawa R, Okuda K, Yonekura Y, Tamaki N, Konishi J, Sasayama S, Yokoyama A: Metabolism and kinetics of I-123-BMIPP in canine myocardium. J Nucl Med 37: 757-761.
  32. Tanaka T, Fujita M, Fudo T, Iwase T, Tamaki S, Nohara R, Sasayama S: Responses of internal mammary artery to local administration of acetylcholine. Am J Cardiol 77: 302-304.
  33. Mortara A, Specchia G, Teresa M, Bigger T, Marcus F, Camm J, Hohnloser S, Nohara R, Schwartz P on Behalf of the ATRAMI Investigators: Patency of infarct-related artery: Effect of restoration of anterograde flow on vagal reflexes. Circulation 93: 1114-1122.
  34. Nohara R, Okuda K, Ogino M, Hosokawa R, Tamaki N, Konishi J, Fujibayashi Y, Yonekura Y, Fujita M, Sasayama S: Evaluation of myocardial viability with Iodine-123-BMIPP in a canine model. J Nucl Med 37: 1403-1407.
  35. Li L, Nohara R, Okuda K, Hosokawa R, Hata T, Tanaka M, Matsumori A, Fujita M, Tamaki N, Konishi J, Sasayama S: Comparative study of 201Tl-scintigraphic image and myocardial pathologic findings in patients with dilated cardiomyopathy. Annals of Nucl Med 10: 307-314.
  36. Okuda K, Nohara R, Ogino M, Tamaki N, Konishi J, Fujita M, Sasayama S: Limitation of infarct size with preconditioning and calcium antagonist (Diltiazem) -Difference in 99mTc-PYP uptake in the myocardium- Annals of Nuclear Medicine10: 201-209.
  37. Tadamura E, Tamaki N, Okazawa H, Fujibayashi Y, Kudoh T, Yonekura Y, Magata Y, Nohara R, Sasayama S, Konishi J: Generator produced Copper-62-PTSM as a myocardial PET perfusion tracer compared with nitrogen-13-ammonia. J Nucl Med 37: 729-735.
  38. Hosokawa R, Nohara R, Fujibayashi Y, Okuda K, Ogino M, Hata t, Fujita M, Tamaki N, Konishi J, Sasayama S: Metabolic fate of iodine-123-BMIPP in canine myocardium after administration of etomoxir. J Nucl Med 37: 1836-1840.
  39. Tateno M, Tamaki N, MYukihiro, KudohT, Hattori N, TadamuraE, Nohara R, Suzuki T, Endo K, Konishi J: Assessment of fatty acid uptake in ischemic heart disease without myocardial infarction. J Nucl Med 37: 1981-1985.
  40. Nakae I, Fujita M, Fudo T, Iwase T, Tanaka T, Tamaki S, Nohara R, Sasayama S: Relation between preexistent coronary collateral circulation and the icidence of restenosis after successful primary coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol 27: 1688-1692.
  41. Horie M, Obayashi K, Xie L-H, James AF, Sasayama S: Hormonal regulation of cardiac Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) chloride channels. Japanese Heart Journal 37: 661-671.
  42. Xie L-H, Horie M, James AF, Watanuki M, Sasayama S: Endothelin-1 inhibits L-type Ca-currents enhanced by isoproterenol in guinea pig ventricular myocytes. Pflugers Archiv 431: 533-539.
  43. Kato S, Ishida H, Tsuura Y, Tsuji K, Nishimura M, Matsubara H, Mizuno N, Horie M, Taminato T, Ikehara S, Ikeda H, Okada Y, Seino Y: Alterations in basal and glucose-stimulated votage-dependent Ca2+ channel activities in pancreatic ｧ cells of non-insulin-dependent diabetes mellitus GK rats. Journal of Clinical Investigation 97: 2417-2425.
  44. Horie M, Watanuki M, Tsuchiya K, Hayashi S, Obayashi K, Xie L-H, Yuzuki Y, Takahashi A, Sasayama S: Autonomic regulation of cardiac ATP-sensitive K+ channel activation. In Recent Progress in Electropharmacology of the Heart, (ed. by J. Toyama, M. Hiraoka, I. Kodama) CRC Press, Boca Raton/New York/London/Tokyo, pp. 73-82.
  45. Ishida-Takahashi A, Horie M, Tsuura Y, Ishida H, Ai T, Sasayama S: Block of pancreatic ATP-sensitive K+ channels and insulinotrophic action by the antiarrhythmic agent, cibenzoline. Br J Pharmacol 117: 1749-1755.
  46. Kihara Y, Inoko M, Hatakeyama N, Momose Y, Sasayama S. Mechanisms of negative inotropic effects of class Ic antiarrhythmic agents: comparative study of the effects of flecainide and pilsicainide on intracellular calcium handling in the dog ventricular myocardium. J Cardiovasc Pharmaclolog 27: 42-51.
  47. Morii I, Kihara Y, Konishi T, Inubshi T, Sasayama S. A mechanism of negative force-frequency relationship in the physiologically intact rat ventricular myocardium: studies by intracellular Ca2+ monitor with indo-1 and by 31P-NMR spectroscopy. Jap Circ J 60: 593-603.
  48. Kihara Y, Inoko M, Sasayama S: Changes of calcium transients during transitions to heart failure: studies in Dahl rat heart failure model. J Cardiac Failure 2: S113-S120.
  49. Kihara Y, Inoko M, Sasayama S: Dahl salt-sensitive rats: a new model to study transitions from compensatory hypertrophy to left ventricular failure. In: Sasayama S, ed. Recent Insights into Failing Heart Syndrome. Springer-Verlag, Tokyo, pp. 105-115.
  50. Kihara Y, Sasayama S: Myocardial calcium handling during ischemia/reperfusion and its modulation with nisoldipine. In: Sasayama S, Kitabatake A, and Takeshita A, eds. International Nisoldipine Symposium Kyoto '95. Excepta Medica, Ltd., Tokyo, pp. 17-29.
  51. Matsuda T, Komori M, Inoue H, Hayashi K, Kimura T, Sasayama S: Another interpretation of Burst imaging as a variation of line projection imaging. Magnetic Resonance in Medicine 36: 796-799.
  52. Ono T, Muso E, Suyama K, Oyama A, Matsushima H, Yashiro M, Kuwahara T, Yoshida H, Kanatsu K, Sasayama S: Intraglomerular deposition of intact cross linked fibrin in IgA nephropathy and Henoch-Scholein purpura nephritis. Nephron 74: 522-528.
  53. Ono T, Nagai H, Kanatsu K, Kudoh T, Onoe C, Utsunomiya K, Hara A, Matsuoka S, Matsushima H, Muso E, Sasayama S: Relationship between obstruction of arteriovenous fistula and plasma level of endothelin-1 in long-term hemodialysis patients. Nephrology 2: 253-256.
  54. Ono T, Sakurai M, Kawamura T, Kamata T, Suyama K, Oyama A, Doi T, Onoe C, Nagai H, Muso E, Sasayama S: Efficacy of amlodipine in hypertensive dialysis patients to deviation of blood pressure during dialysis. Ther. Res. 17: 4951-4959.
  55. McGrew M J, Bogdanova N, Hasegawa K, Hughes S H, Kitsis R N, Rosenthal N: Distinct gene expression patterns in skeletal and cardiac muscle are dependent on common regulatory sequences in the MLC1/3 locus. Mol Cell Biol 16: 4524-4534.
  56. Doyama K, Fujiwara H, Fukumoto M, Tanaka M, Fujiwara Y, Oda T, Inada T, Ohtani S, Hasegawa K, Fujiwara T, Sasayama S: Tumour necrosis factor is expressed in cardiac tissues of patients with heart failure. Int J Cardiol 54: 217-225.
  57. Hasegawa K, Fujiwara H, Koshiji M, Inada T, Ohtani T, Doyama K, Tanaka M, Matsumori A, Fujiwara T, Shirakami G, Hosoda K, Nakao K, Sasayama S: Endothelin-1 and its receptor in hypertrophic cardiomyopathy. Hypertension 27: 259-264.
  58. Htay T, Fujiwara H, Sato M, Tanaka M, Sasayama S, Inoue K: Transcatheter inoue endovascular graft for treatment of canine aortic dissection. Heart Vessels 11: 80-85.
  59. Hattori R, Yui Y,Shinoda E, Inoue R, Aoyama T, Masayasu H, Kawai C, Sasayama S: Effect of ebselen on bovine and rat nitric oxide synthase activity is modified by thiols. Jpn J Pharm 72: 191-193.
  60. Brenn T, Aoyama T, Franck U, Furthmayr H: Dermal fibroblast culture as a model system for studies of fibrillin assembly and pathogenetic mechanisms: Defects in distinct groups of individuals with Marfanﾕs syndrome. Lab Invest l75: 389-402.
  61. Fujita M, Ikemoto M, Kishishita M, Otani H, Nohara R, Tanaka T, Tamaki S, Yamazato A, Sasayama S: Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. Circulation 94: 610-613.
  62. Nakamura Y, Kawai C, Moss AJ, Raubertas RF, Brown MW, Kinoshita M, Sasayama S, Nonogi H, Omae T, Tamaki S, Fujita M, Tanaka N, Hosoda S, Inoue H, Sugimoto T, Iinuma H, Kato K, Tamaki N, Sugiura N: Comparison between Japan and North America in the post-hospital course after recovery from an acute coronary event. Int J Cardiol 55: 245-254.
  63. Miwa K, Miyagi Y, Fujita M: LDL oxidation and variant angina: role of methodological procedures in LDL oxidizability assessment (Reply). J Am Coll Cardiol 28: 1637.
                ｜ 業績リストTOP ｜1997年 >>
ページの先頭へ